Inventor · disambiguated record
Guido Kroemer
Also filed as: KROEMER GUIDO · KROEMER GUIDO P · KROEMER GUIDO PETER
19 granted patents·20 pending applications·242 citations·filing 1994–2025
93Inventor score
Files withINST NAT SANTE RECH MED9ROUSSY INST GUSTAVE3KROEMER GUIDO2PHARMA MAR SA2SAMSARA THERAPEUTICS INC2
Top patents by PatentIndex Score
39 records- 0189US8865653B2Method of treatment for immunogenic treatment resistant cancerROUSSY INST GUSTAVE·Filed 2013·Granted Oct 21, 2014·7 cites·7 claims
- 0289US5776947AUse of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shockPHARMACIA AB·Filed 1994·Granted Jul 7, 1998·110 cites·5 claims
- 0383US8129340B2Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereofKROEMER GUIDO·Filed 2007·Granted Mar 6, 2012·3 cites·10 claims
- 0482US6319931B1Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapyCT NAT DE AL RECH SCIENT CNRS·Filed 1999·Granted Nov 20, 2001·88 cites·9 claims
- 0581US12343376B2Methods for inhibiting diazepam binding proteinINST NAT SANTE RECH MED·Filed 2024·Granted Jul 1, 2025·0 cites·17 claims
- 0679US9132123B2Combined therapy for cystic fibrosisI E R F C EUROP INST FOR CYSTIC FIBROSIS RES·Filed 2013·Granted Sep 15, 2015·6 cites·8 claims
- 0775US11905330B1Methods for weight reductionINST NAT SANTE RECH MED·Filed 2022·Granted Feb 20, 2024·0 cites·11 claims
- 0874US8828944B2Compounds and uses thereof to induce an immunogenic cancer cell death in a subjectZITVOGEL LAURENCE·Filed 2011·Granted Sep 9, 2014·3 cites·2 claims
- 0974US8557517B2Toll like receptor 4 dysfunction and the biological applications thereofAPETOH LIONEL·Filed 2007·Granted Oct 15, 2013·4 cites·30 claims
- 1071US7642051B2Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)PASTEUR INSTITUT·Filed 2005·Granted Jan 5, 2010·3 cites·12 claims
- 1169US8263344B2Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatmentKROEMER GUIDO·Filed 2007·Granted Sep 11, 2012·5 cites·6 claims
- 1269US7056735B2Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator)UNIV COMPIEGNE TECH·Filed 2001·Granted Jun 6, 2006·4 cites·25 claims
- 1369US2025051430A1Neutralization of acyl-coa binding protein confers autophagy-dependent organ protectionINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 1464US11040052B2Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereofINST NAT SANTE RECH MED·Filed 2018·Granted Jun 22, 2021·1 cites·12 claims
- 1564US7371834B2Apoptosis-inducing factorAMGEN INC·Filed 2002·Granted May 13, 2008·1 cites·12 claims
- 1662US2025034127A1Autophagy inducing compounds and uses thereof, in particular for diseases of the cnsSAMSARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1762US2025049776A1Autophagy inducing compounds and uses thereof, in particular for a systemic treatment of diseases and conditionsSAMSARA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1862US2020268837A1Methods and pharmaceutical compositions for modulating autophagyINSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2018·Application pending·0 cites
- 1961US9726661B2Simultaneous detection of cannibalism and senescence as prognostic marker for cancerINST GUSTAVE-ROUSSY·Filed 2013·Granted Aug 8, 2017·1 cites·8 claims
- 2060US10969380B2Simultaneous detection of cannibalism and senescence as prognostic marker for cancerROUSSY INST GUSTAVE·Filed 2017·Granted Apr 6, 2021·0 cites·15 claims
- 2158US2025295656A1Combination of lurbinectedin and immune checkpoint inhibitorsPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 2257US2023310426A1Combination of lurbinectedin and immune checkpoint inhibitorPHARMA MAR SA·Filed 2021·Application pending·0 cites
- 2356US2011229411A1Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatmentROUSSY INST GUSTAVE·Filed 2008·Application pending·0 cites
- 2455US2010136137A1Therapeutic combination of a panher/vegfr2 kinase inhibitor and a platinum compoundBRISTOL MEYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2552US2020297749A1Methods and Pharmaceutical Composition for Modulation Polarization and Activation of MacrophagesINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 2649US2018125876A1Methods and Pharmaceutical Composition for Modulation Polarization and Activation of MacrophagesINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 2748US9938528B2Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infectionsINST NAT SANTE RECH MED·Filed 2015·Granted Apr 10, 2018·0 cites·19 claims
- 2846US9730922B2Combined therapy for cystic fibrosisI E R F C EUROPEAN INST FOR CYSTIC FIBROSIS RES·Filed 2015·Granted Aug 15, 2017·0 cites·19 claims
- 2944US2023113705A1Methods for diagnosing, prognosing and managing treatment of breast cancerINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 3044US2021030703A1Use of caloric restriction mimetics for potentiating chemo-immunotherapy for the treatment of cancersINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 3144US2016031955A1Methods for Treating Mitochondrial Disorders and Neurodegenerative DisordersINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2014·Application pending·0 cites
- 3244US2004072146A1Mechanism of mitochondrial membrane permeabilization by HIV-1 Vpr, mimetics of Vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of Vpr with ANTFiled 2003·Application pending·0 cites
- 3343US2008299101A1Cancer Treatment Resistance and Agents Modulating Such ResistanceCENTRE NAT RECH SCIENT·Filed 2005·Application pending·0 cites
- 3442US2013156791A1Methods and pharmaceutical compositions for the treatment of hiv-1 infectionsPERFETTINI JEAN-LUC·Filed 2011·Application pending·0 cites
- 3539US6773911B1Apoptosis-inducing factorAMGEN CANADA INC·Filed 1999·Granted Aug 10, 2004·6 cites·27 claims
- 3639US2020360305A1Use of triethylenetetramine (teta) for the therapeutic induction of autophagyINSERM INSTITUT NATIONAL DE LA SSNTE ET DE LA RES MEDECALE·Filed 2018·Application pending·0 cites
- 3737US2016250249A1Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereofINSERM ( INST NAT DE LASANTÉ ET DE LA RE CHERCHE MÉDICALE)·Filed 2014·Application pending·0 cites
- 3832US2013281313A1Prognostic and/or predictive biomarkers and biological applications thereofGALLUZZI LORENZO·Filed 2011·Application pending·0 cites
- 3930US2003166598A1Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agentFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guido Kroemer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →